STAT

Congress isn’t acting to curb drug prices, so states are stepping up. Here’s how

With little action in Congress, states from California to Vermont are experimenting with ways to try to curb drug prices or shine a light on rising costs.

President Trump has complained that drug makers are getting away with murder — and he may be right.

Despite vociferous complaints from consumers that drug prices are too high, Congress has failed to act. And with few exceptions, the pharmaceutical industry has successfully delayed or thwarted state bills that would force drug makers to explain or justify price hikes.

But that may be starting to change. Last week, of the pharma industry, already has a similar policy in place.  recently began requiring drug makers to disclose pricing data about diabetes medicines. And has a new law that penalizes generic companies for price gouging.

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readScience
Amid Privacy Concerns, Startup Becomes First Consumer DNA Company To Offer Anonymous Sequencing
Nebula will offer anonymous testing amid public concerns about the privacy of genetic data and law enforcement use of public DNA databases to identify suspects.
STAT3 min readPolitics
Pelosi’s Drug Pricing Plan Would Let Medicare Negotiate Prices For Up To 250 Drugs
The new legislation is more aggressive than prior concepts that had circulated among lobbyists and congressional staff this year.
STAT3 min readSociety
Number Of Vaping-related Illnesses In U.S. Has Spiked, CDC Says
While many of the people who have developed lung problems reported using THC — the active ingredient in cannabis — a number have said they did not vape THC.